Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Muscle Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06462001
What this trial is testing

BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer

Who this might be right for
Transitional Cell CarcinomaTransurethral Resection
Nottingham University Hospitals NHS Trust 500
Not applicableUnknownNCT04966130
What this trial is testing

Effect of Urinary Indwelling Time on Early Continence After Robot-assisted Radical Cystectomy With Orthotopic Ileal Neobladder.

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 96
Post-approval studies (Phase 4)UnknownNCT02288130
What this trial is testing

Ulipristal vs. GnRHa Prior to Laparoscopic Myomectomy

Who this might be right for
Fibroids
Amsterdam UMC, location VUmc 100
Not applicableUnknownNCT05671900
What this trial is testing

Gemcitabine and Docetaxel Therapy in High-risk BCG-naive Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
Clinical Hospital Centre Zagreb 70
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Not applicableLooking for participantsNCT04067167
What this trial is testing

Flexi Band Resistance Training Versus EMS Exercise in Patients With the Diagnosis of Malignant Diseases

Who this might be right for
CancerCancer CachexiaInflammation+1 more
University of Erlangen-Nürnberg Medical School 100
Not applicableStudy completedNCT03838757
What this trial is testing

Maximal Exercise Capacity and Extra-pulmonary Characteristics in Patients With Lung Cancer With Complete Remission .

Who this might be right for
Lung Cancer
Gazi University 40
Large-scale testing (Phase 3)Study completedNCT00002995
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 483
Early research (Phase 1)UnknownNCT04134000
What this trial is testing

Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)

Who this might be right for
Invasive Bladder Cancer
Fundacion Oncosur 40
Not applicableNot Yet RecruitingNCT07158892
What this trial is testing

Understanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test

Who this might be right for
Non-traumatic Musculoskeletal ConditionsCarpal Tunnel Syndrome (CTS)Lateral Epicondylitis+5 more
University of Texas at Austin 220
Large-scale testing (Phase 3)Study completedNCT01156857
What this trial is testing

PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata

Who this might be right for
Uterine Fibroids
PregLem SA 209
Not applicableNot Yet RecruitingNCT07732101
What this trial is testing

Exercise Intervention for Breast Cancer Patients With Sarcopenia

Who this might be right for
SarcopeniaBreast Cancer
Capital Medical University 104
Not applicableStudy completedNCT01152112
What this trial is testing

HOME Study: Hysteroscopic Office Myomectomy Evaluation

Who this might be right for
Uterine FibroidsPolyps
Hologic, Inc. 74
Testing effectiveness (Phase 2)Study completedNCT05694819
What this trial is testing

Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)

Who this might be right for
Salivary Gland Cancer
National Cancer Center Hospital East 57
Not applicableUnknownNCT03362801
What this trial is testing

SArcopenia, Mobility, PHYsical Activity and Post-operative Risk of Bladder Carcinoma in the Elderly

Who this might be right for
SarcopeniaBladder Cancer
University Hospital, Caen 69
Post-approval studies (Phase 4)Ended earlyNCT01555073
What this trial is testing

Preemptive Analgesia Following Uterine Artery Embolization

Who this might be right for
Uterine FibroidsUterine Artery Embolization
Northwestern University 23
Not applicableStudy completedNCT01032213
What this trial is testing

Effect of Magnesium Sulphate on Coagulation

Who this might be right for
Myoma
Seoul National University Bundang Hospital 40
Large-scale testing (Phase 3)Study completedNCT04756037
What this trial is testing

Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy

Who this might be right for
Contraception
Sumitomo Pharma Switzerland GmbH 1,164
Early research (Phase 1)Study completedNCT06100653
What this trial is testing

BCG for Therapeutic Use Phase I Clinical Trial

Who this might be right for
Non-muscular Invasive Bladder Cancer
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 10
Testing effectiveness (Phase 2)WithdrawnNCT04040725
What this trial is testing

Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression

Who this might be right for
Bladder Cancer
Dana-Farber Cancer Institute
Next Page